2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide

C119H143N13O16S5 — CID 157125943

IUPAC2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide
SMILESC#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCCCC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCCCC2)[nH]1.Cc1cnc(C(=O)Cc2ccc(CS(=O)(=O)N3CCOCC3)cc2C2=CCCCC2)[nH]1
InChIInChI=1S/C25H31N3O3S.C25H30N2O3S.C23H29N3O4S.C23H27N3O3S.C23H26N2O3S/c1-6-21-17-26-24(27-21)23(29)16-20-8-7-18(11-14-32(30,31)28(4)5)15-22(20)19-9-12-25(2,3)13-10-19;1-5-21-17-26-24(27-21)23(28)16-20-8-7-18(11-14-31(29,30)6-2)15-22(20)19-9-12-25(3,4)13-10-19;1-17-15-24-23(25-17)22(27)14-20-8-7-18(13-21(20)19-5-3-2-4-6-19)16-31(28,29)26-9-11-30-12-10-26;1-4-20-16-24-23(25-20)22(27)15-19-11-10-17(12-13-30(28,29)26(2)3)14-21(19)18-8-6-5-7-9-18;1-3-20-16-24-23(25-20)22(26)15-19-11-10-17(12-13-29(27,28)4-2)14-21(19)18-8-6-5-7-9-18/h1,7-9,15,17H,10-14,16H2,2-5H3,(H,26,27);1,7-9,15,17H,6,10-14,16H2,2-4H3,(H,26,27);5,7-8,13,15H,2-4,6,9-12,14,16H2,1H3,(H,24,25);1,8,10-11,14,16H,5-7,9,12-13,15H2,2-3H3,(H,24,25);1,8,10-11,14,16H,4-7,9,12-13,15H2,2H3,(H,24,25)
InChIKeyAIMUARAPZXYPKN-UHFFFAOYSA-N
MW2171.86 g/mol
LogP18.45
Rot. Bonds39

About 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide

2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide (PubChem CID 157125943) has the molecular formula C119H143N13O16S5 and a molecular weight of 2171.86 g/mol. Its IUPAC name is 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide.

Molecular Properties

Compound Name2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide
PubChem CID157125943
Molecular FormulaC119H143N13O16S5
Molecular Weight2171.86 g/mol
Exact Mass2169.94
IUPAC Name2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide
SMILESC#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCCCC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCCCC2)[nH]1.Cc1cnc(C(=O)Cc2ccc(CS(=O)(=O)N3CCOCC3)cc2C2=CCCCC2)[nH]1
InChIInChI=1S/C25H31N3O3S.C25H30N2O3S.C23H29N3O4S.C23H27N3O3S.C23H26N2O3S/c1-6-21-17-26-24(27-21)23(29)16-20-8-7-18(11-14-32(30,31)28(4)5)15-22(20)19-9-12-25(2,3)13-10-19;1-5-21-17-26-24(27-21)23(28)16-20-8-7-18(11-14-31(29,30)6-2)15-22(20)19-9-12-25(3,4)13-10-19;1-17-15-24-23(25-17)22(27)14-20-8-7-18(13-21(20)19-5-3-2-4-6-19)16-31(28,29)26-9-11-30-12-10-26;1-4-20-16-24-23(25-20)22(27)15-19-11-10-17(12-13-30(28,29)26(2)3)14-21(19)18-8-6-5-7-9-18;1-3-20-16-24-23(25-20)22(26)15-19-11-10-17(12-13-29(27,28)4-2)14-21(19)18-8-6-5-7-9-18/h1,7-9,15,17H,10-14,16H2,2-5H3,(H,26,27);1,7-9,15,17H,6,10-14,16H2,2-4H3,(H,26,27);5,7-8,13,15H,2-4,6,9-12,14,16H2,1H3,(H,24,25);1,8,10-11,14,16H,5-7,9,12-13,15H2,2-3H3,(H,24,25);1,8,10-11,14,16H,4-7,9,12-13,15H2,2H3,(H,24,25)
InChIKeyAIMUARAPZXYPKN-UHFFFAOYSA-N
XLogP18.45
TPSA418.40 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds39
Heavy Atoms153
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002171.86
LogP ≤ 518.45
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide?
The IUPAC name of 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide (CID 157125943) is 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide.
What is the SMILES notation for 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide?
The canonical SMILES for 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide is C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)CC)cc2C2=CCCCC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCC(C)(C)CC2)[nH]1.C#Cc1cnc(C(=O)Cc2ccc(CCS(=O)(=O)N(C)C)cc2C2=CCCCC2)[nH]1.Cc1cnc(C(=O)Cc2ccc(CS(=O)(=O)N3CCOCC3)cc2C2=CCCCC2)[nH]1.
What is the InChIKey of 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide?
The InChIKey is AIMUARAPZXYPKN-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31N3O3S.C25H30N2O3S.C23H29N3O4S.C23H27N3O3S.C23H26N2O3S/c1-6-21-17-26-24(27-21)23(29)16-20-8-7-18(11-14-32(30,31)28(4)5)15-22(20)19-9-12-25(2,3)13-10-19;1-5-21-17-26-24(27-21)23(28)16-20-8-7-18(11-14-31(29,30)6-2)15-22(20)19-9-12-25(3,4)13-10-19;1-17-15-24-23(25-17)22(27)14-20-8-7-18(13-21(20)19-5-3-2-4-6-19)16-31(28,29)26-9-11-30-12-10-26;1-4-20-16-24-23(25-20)22(27)15-19-11-10-17(12-13-30(28,29)26(2)3)14-21(19)18-8-6-5-7-9-18;1-3-20-16-24-23(25-20)22(26)15-19-11-10-17(12-13-29(27,28)4-2)14-21(19)18-8-6-5-7-9-18/h1,7-9,15,17H,10-14,16H2,2-5H3,(H,26,27);1,7-9,15,17H,6,10-14,16H2,2-4H3,(H,26,27);5,7-8,13,15H,2-4,6,9-12,14,16H2,1H3,(H,24,25);1,8,10-11,14,16H,5-7,9,12-13,15H2,2-3H3,(H,24,25);1,8,10-11,14,16H,4-7,9,12-13,15H2,2H3,(H,24,25).
What are the key properties of 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide?
2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide has a molecular weight of 2171.86 g/mol, XLogP of 18.45, 39 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(cyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(cyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide;2-[2-(cyclohexen-1-yl)-4-(morpholin-4-ylsulfonylmethyl)phenyl]-1-(5-methyl-1H-imidazol-2-yl)ethanone;2-[2-(4,4-dimethylcyclohexen-1-yl)-4-(2-ethylsulfonylethyl)phenyl]-1-(5-ethynyl-1H-imidazol-2-yl)ethanone;2-[3-(4,4-dimethylcyclohexen-1-yl)-4-[2-(5-ethynyl-1H-imidazol-2-yl)-2-oxoethyl]phenyl]-N,N-dimethylethanesulfonamide is sourced from PubChem (CID 157125943), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).